* Industry diversification based on Moody's industry classification. Measured as the fair value of investments for each category against the total fair value of all investments. Totals may not sum due to rounding.
A balanced portfolio built on the cornerstones of diversification and selectivity
Anchored in senior secured loans, NCDL has built a scaled and diversified portfolio by industry, investment type and portfolio company. Selectivity, diversification and rigorous underwriting are key to our investment philosophy, enabling strong credit performance since inception.
Portfolio holdings
Top ten positions
Represents the top ten positions in NCDL based on Fair Value as of March 31, 2026
| Company | Fair value ($ in thousands) | Industry | Asset Types | Pricing1 |
|---|---|---|---|---|
| KRIV Co-Invest Holdings, L.P. (Riveron) | 1,103,872.00 | Services: Business | Equity Investment | |
| SI Solutions, LLC | 1,109,006.91 | Environmental Industries | First Lien Debt (Delayed Draw) | S + 4.75% |
| Big Apple Advisory, LLC | 1,111,083.10 | Banking, Finance, Insurance & Real Estate | First Lien Debt (Delayed Draw) | S + 4.50% |
| VMG Holdings LLC (VMG Health) | 1,116,459.04 | Healthcare & Pharmaceuticals | First Lien Debt | S + 5.00% |
| RMS Energy Borrower LLC | 1,118,663.92 | Utilities: Electric | First Lien Debt (Delayed Draw) | S + 4.50% |
| RA Parent Holdings LP (S&S Truck Parts) | 1,127,157.44 | Automotive | First Lien Debt | S + 4.75% |
| CRCI Longhorn Holdings, Inc. (CRCI Holdings Inc) | 1,136,177.43 | Utilities: Electric | First Lien Debt (Delayed Draw) | S + 4.75% |
| KKEMP Blocked Co-Invest, LP | 1,159,841.00 | Services: Business | Equity Investment | |
| Caldwell & Gregory LLC | 1,167,401.56 | Services: Business | Subordinated Debt | 9.98% (Cash) 2.50% (PIK) |
| Wellspring Pharmaceutical Corporation | 1211643.54 | Healthcare & Pharmaceuticals | First Lien Debt | S + 4.50% |
| Bardstown PPC Buyer LLC (Bardstown Bourbon Company) | 1,228,288.75 | Beverage, Food & Tobacco | Equity Investment | |
| Promptcare Infusion Buyer, Inc. | 1,245,362.96 | Healthcare & Pharmaceuticals | First Lien Debt (Delayed Draw) | S + 6.00% |
| Entomo Brands Acquisitions, Inc. (Palmetto Exterminators) | 1,246,322.09 | Services: Consumer | Equity Investment | |
| Gannett Fleming, Inc. | 1,265,939.80 | Construction & Building | Revolving Loan | S + 4.50% |
| MBS Holdings, Inc. | 1,281,458.34 | Telecommunications | First Lien Debt | S + 5.00% |
| OSP Gannett Aggregator, LP (Gannett Fleming) | 1,309,705.35 | Construction & Building | Equity Investment | |
| Phoenix Topco Holdings LP (S&S Truck Parts) | 1,324,102.85 | Automotive | Equity Investment | |
| Genesee Scientific LLC | 1,331,608.25 | Healthcare & Pharmaceuticals | First Lien Debt (Delayed Draw) | S + 5.75% |
| Anne Arundel Dermatology Management, LLC | 1,336,603.17 | Healthcare & Pharmaceuticals | Subordinated Debt | 12.75% (PIK) |
| CPL Consultants, LLC | 1,339,979.83 | Services: Business | First Lien Debt | S + 4.25% |
| Chroma Color Corporation | 1,343,584.05 | Chemicals, Plastics & Rubber | First Lien Debt (Delayed Draw) | S + 4.25% |
| AB Centers Acquisition Corporation (Action Behavior Centers) | 1,349,473.86 | Healthcare & Pharmaceuticals | First Lien Debt (Delayed Draw) | S + 5.25% |
| RCP Nats Co-Investment Fund LP | 1,362,291.00 | Healthcare & Pharmaceuticals | Equity Investment | |
| Promptcare Infusion Buyer, Inc. | 1,408,599.02 | Healthcare & Pharmaceuticals | First Lien Debt (Delayed Draw) | S + 6.00% |
| New Spartech Holdings LLC | 1,430,524.73 | Chemicals, Plastics & Rubber | First Lien Debt | S + 7.00% |
| AB Centers Acquisition Corporation (Action Behavior Centers) | 1,435,872.13 | Healthcare & Pharmaceuticals | First Lien Debt | S + 5.25% |
| JEGS Automotive | 1,439,088.51 | Automotive | First Lien Debt | 12.59% (PIK) |
| GNX HBS Parent, LLC | 1,444,148.15 | High Tech Industries | First Lien Debt (Delayed Draw) | S + 4.50% |
| DH United Holdings, LLC (D&H United Fueling Solutions) | 1,515,714.84 | Services: Business | First Lien Debt (Delayed Draw) | S + 5.00% |
| Wellspring Pharmaceutical Corporation | 1527883.65 | Healthcare & Pharmaceuticals | First Lien Debt (Delayed Draw) | S + 4.50% |
1. The majority of the investments bear interest at rates that may be determined by reference to Secured Overnight Financing Rate ("SOFR" or "S"), which reset monthly or quarterly. For each such investment, the Company has provided the spread over SOFR and the current contractual interest rate in effect at June 30, 2026. As of June 30, 2026, rates for 1M S, 3M S, 6M S, 12M S ("SOFR") are 3.65%, 3.73%, 3.85%, and 3.99% respectively. Certain investments are subject to a SOFR floor or may utilize an alternative reference rate such as U.S. Prime Rate (“P”). For fixed rate loans, a spread above a reference rate is not applicable.